Effects of Ciji Hua’ai baosheng formula on apoptosis correlation factors of tumor chemotherapy model mouse with H22hepatoma carcinoma cells

African Journal of Traditional, Complementary and Alternative Medicines

Volumn 12, Issue 4, 2015, Pages 72-78

  Cheng, Yao ^a   Xi, Shengyan ^a   Wang, Yanhui ^a   Gong, Yuewen ^b   Xu, Yangxinzi ^b   Shi, Mengmeng ^a   Loy, Guanjie ^a   Zhao, Xinyue ^a  

^a XIAMEN UNIVERSITY   (China)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Bax; Bcl 2; Caspase 3; Ciji hua ai baosheng formula (CHBF); CyclinD1; Epidermal growth factor receptor (EGFR); H22hepatoma carcinoma cell; Tumor chemotherapy model

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CIJI HUA AI BAOSHENG; CYCLIN D1; CYCLOPHOSPHAMIDE; EPIDERMAL GROWTH FACTOR RECEPTOR; HERBACEOUS AGENT; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; HEPATOMA CELL; LIVER CELL CARCINOMA; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

EID: 84938577242     PISSN: None     EISSN: 25050044     Source Type: Journal    
DOI: 10.4314/ajtcam.v12i4.11     Document Type: Article

References (26)

1. Adams JM, Cory S. (2007). Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Current Opinion in Immunology, 19(5): 488-496.
2. Blanc C, Deveraux QL, Krajewski S, Jänicke RU, Porter AG, Reed JC, Jaggi R, Marti A. (2000). Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Research, 60(16): 4386-4390.
3. Burikhanov R, Shrestha-Bhattarai T, Qiu S, Shukla N, Hebbar N, Lele SM, Horbinski C, Rangnekar VM. (2013). Novel Mechanism of Apoptosis Resistance in Cancer Mediated by Extracellular PAR-4. Cancer Research, 73(2): 1011-1019.
4. Chen CJ, Yu ZJ, LV YL, Cai Y. (2014). Research of Allicin's anti-cancer effects on HepG-2 cell line. Chinese Archives of Traditional Chinese Medicine, 32(7): 1763-1767.
5. Dai ZJ, Wang XJ, Li ZF, Ji ZZ, Ren HT, Tang W, Liu XX, Kang HF, Guan HT, Song LQ. (2008). Scutellaria barbate extract induces apoptosis of hepatoma H22 cells via the mitochondrial pathway involving caspase-3. World Journal of Gastroenterology, 14(48): 7321-7328.
6. Feng Y, Dai X, Li X, Wang H, Liu J, Zhang J, Du Y, Xia L. (2012). EGF signaling pathway regulates colon cancer stem cell proliferation and apoptosis. Cell Proliferation, 45(5): 413-419.
7. He KQ, Xi SY, Li PC. (2014). Academic and clinical experience of professor WANG Yan-hui in treatment for cancer with heavy prescription. China Journal of Traditional Chinese Medicine and Pharmacy, 29(7): 2240-2242.
8. Lai PH, Wang YH, Li PC, Lu DW. (2014). Experience of professor WANG Yan-hui in treating tumor based on 'tumor is the pathologic products'. China Journal of Traditional Chinese Medicine and Pharmacy, 29(10): 3139-3141.
9. Jana S, Paliwal J. (2007). Apoptosis: Potential therapeutic targets for new drug discovery. Current Medicinal Chemistry, 14(22): 2369-2379.
10. Liang CZ, Zhang JK, Shi ZL, Liu B, Shen CQ, Tao HM. (2012). Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2. Cancer Chemotherapy Pharmacology, 69(2): 317-331.
11. Li CJ, Sun JL, Liu LS, Sun XY. (2010). Regulatory effect of strengthening qi and nourishing yin recipe on expressions of ERα and CyclinD1 of Lewis lung cancer in C57 mice. China Journal of Traditional Chinese Medicine and Pharmacy, 25(4): 578-581.
12. Liu W, Innocenti F, Chen P, Das S, Cook EH Jr, Ratain MJ. (2003). Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism. Clinical Cancer Research, 9(3): 1009-1012.
13. Lui VW, Grandis JR. (2002). EGFR-mediated cell cycle regulation. Anticancer Research, 22(1A): 1-11.
14. McKay JA, Murray LJ, Curran S, Ross VG, Clark C, Murray GI, Cassidy J, McLeod HL. (2002). Evaluation of the epidermal growth factor receptor (EGFR) in colorectal tumours and lymph node metastases. European Journal of Cancer, 38(17): 2258-2264.
15. Meiler J, Schuler M. (2006). Therapeutic targeting of apoptotic pathways in cancer. Current Drug Targets, 7(10): 1361-1369.
16. Nan SL, Wu GX, He S, Huang LQ, Zhang FH. (2014). Preliminary study on anti-tumor effect of sinapine on mice with H22 hepatocellular carcinoma. China Journal of Traditional Chinese Medicine and Pharmacy, 29(11): 3618-3622.
17. Raymond E, Faivre S, Armand JP. (2000). Epidermal growth factor receptor tyrosine kinase as a target for anticancer therapy. Drugs, 60(suppl 1): 15-23.
18. Tidow N, Boecker A, Schmidt H, Agelopoulos K, Boecker W, Buerger H, Brandt B. (2003). Distinct amplification of an untranslated regulatory sequence in the egfr gene contributes to early steps in breast cancer development. Cancer Research, 63(6): 1172-1178.
19. Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J. (2001). Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology. Cancer Radiotherapy, 5(2): 109-129.
20. Wang YH. (2004). The application of TCM method 'He' in preventing and curing the toxic and side-effect from chemotherapy to malignant tumor. Journal of Gansu College of Traditional Chinese Medicine, 21(3): 9-11.
21. Wang YH, Shen XY. (2004). Emphasis of TCM recuperative medical care on post-chemotherapy to malignant tumor is 'treatment should focus on the principal cause of a disease'. Journal of Gansu College of Traditional Chinese Medicine, 21(4): 6-7.
22. Xi SY, Hong RJ, Huang JR, Lu DW, Qian LC, Li PC, Wen L, Wang YH. (2014). Effects of Ciji Hua'ai Baosheng Granule Formula (CHBGF) on life time, pathology, Peripheral blood cells of tumor chemotherapy model mouse with H22 hepatoma carcinoma cells. African Journal of Traditional, Complementary and Alternative Medicines, 11(4): 94-100.
23. Xu HY, Lin NM, Xu L, Luo M. (2011). Experimental research of Shaoyao Ruangan Fang on anti-tumor effect in hepatoma H22 bearing mice and Sarcoma S180 bearing mice. China Cancer, 20(11): 850-854.
24. Yeo AT, Porco JA Jr, Gilmore TD. (2012). Bcl-XL, but not Bcl-2, can protect human B-lymphoma cell lines from parthenolide-induced apoptosis. Cancer Letters, 318(1): 53-60.
25. Yuan AH, Li ZF, Li XQ, Yi SY, Wang SK, Shi KW, Bian JM. (2009). Distinct effect of Chrysanthemum indicum Linne extracts on isoproterenol-induced growth of human hepatocellular carcinoma cells. Oncology Reports, 22(6): 1357-1363.
26. Zhao YN, Cao J, Wu FX, Ou C, Yuan WP, Mo QG, Wei W, Li Y, Su JJ, Liang AM. (2004). Expression and Significance of EGF mRNA and EGFR mRNAin Hepatocellular Carcinoma. Chinese Journal of Cancer, 23(7): 762-766.